ArticleFrontiers in psychiatry2025
Multidimensional EEG features integration with feature selection strategy for precision diagnosis of depressive disorders.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depressive disorder (DD), a leading global cause of disability, lacks objective diagnostic biomarkers due to reliance on subjective clinical criteria. This study introduces an algorithm-driven framework integrating multidimensional EEG features, dynamic time-window optimization, feature selection and machine learning to address this gap. Resting-state EEG signals were acquired from 70 DD patients and 30 healthy controls (HC). Three-dimensional neurophysiological features, including power spectral density (PSD), sample entropy (SE), and phase lag index (PLI), were systematically extracted across variable time windows. The SVM-RFE algorithm eliminated redundant features, identifying an optimal subset that maximized classification accuracy through leave-one-subject-out cross-validation. Our model achieved exceptional classification accuracy of 94.48% using 10-second windows, outperforming conventional approaches. Critical biomarkers included beta rhythm alterations and cross-frequency functional connectivity patterns, demonstrating superior discriminative power for DD patients. The optimal feature subset emphasized the combined significance of spectral, nonlinear dynamic, and network-level characteristics in differentiating DD from HC. This framework establishes the first evidence-based integration of time-window and feature selection optimized multidimensional EEG features for DD identification, resolving key limitations in replicability and clinical translatability of existing methods. Beyond enabling high-precision objective diagnosis, the biomarker profile provides mechanistic insights into DD neuropathology, particularly beta rhythm dysregulation and aberrant cross-frequency coupling. These findings advance EEG-based precision psychiatry by offering a validated protocol for therapeutic monitoring and treatment personalization, bridging the critical gap between computational neuroscience and clinical practice in mood disorder management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.